InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Poulton Stuart, Directeur du Développement. Insider active across 1 companies, notably Karyopharm Therapeutics Inc.. Cumulatively, 2 filings have been recorded. The latest transaction was disclosed on 13 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
0896 shares0
Common Stock
SEC:0001193125-26-226697·
0896 shares0
Common Stock
SEC:0001193125-26-226697:0·
2 of 2 declarations
About Poulton Stuart
Poulton Stuart is the Chief Development Officer at Karyopharm Therapeutics Inc. He is responsible for developing and implementing product development strategies. His expertise is crucial for the success of the company's research and development initiatives.
